Taking the Pulse: a Health Care and Life Sciences Podcast · Taking The Pulse

Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare

·17 min·1 clip
Patrick McCarthy applies Harvard's 'Innovator's Dilemma' theory to explain why big pharma resists simplifying clinical trials.
Patrick McCarthy, CEO of Validcare, discusses how his company is using a unified technology platform to simplify and reduce the cost of clinical trials. He explains the disruption to traditional contract research organization models, the challenges of changing entrenched industry practices, and the potential for more accessible, patient-centric research.

As heard by us

Clinical trials are framed as an operations problem as much as a scientific one, with clear stakes for smaller sponsors and larger teams.

Patrick McCarthy's segment on ValidCare keeps returning to a simple point: clinical trials are not only science, they are operations. The episode makes that case through budget pressure, compliance work, and the effort to cut repetitive tasks so smaller life sciences companies…

Read the full review in PlayNext →

Why you'd press play

A practical case for redesigning clinical trials so compliance studies are easier to run.

Read the full recommendation in PlayNext →
Listen to the show on